Stephen Mounsey finds out about the computing power behind some of the world's most ambitious scientific projects
Greg Blackman looks at the role LIMS, as well as data management software as a whole, plays in putting food on our plates
Felix Grant explores the role of statistical analysis in the field of invention
HPC system architects are increasingly turning to alternative interconnects such as InfiniBand to replace Ethernet in many situations. Paul Schreier examines what is driving this trend
Bruce Klimpke, technical director of Integrated Engineering Software, looks at 25 years of simulation software
Saving untold hours in the laboratory, molecular modelling software allows researchers to determine how to make useful changes to existing substances or make new ones. Paul Schreier takes a glimpse of the tools and techniques researchers are using to find the molecules that will bring us improved drugs and materials
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
